64 results on '"GABRIEL, Sylvie"'
Search Results
2. Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real‐world evidence claims data study
3. Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network
4. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis
5. Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France
6. Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice
7. An explanatory sequential mixed-methods design to establish thresholds of within-individual meaningful change on a sleep disturbance numerical rating scale score in atopic dermatitis
8. Association between prurigo nodularis and substance use disorders
9. 34095 Observed and projected prevalence of prurigo nodularis in a commercially and Medicare-insured U.S. population
10. Longitudinal course and predictors of depressive symptoms in atopic dermatitis
11. Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study
12. Epidemiology of prurigo nodularis in England: a retrospective database analysis
13. A real-world study of the longitudinal course of skin pain in adult atopic dermatitis
14. Un lieu de coopération des métiers de l’édition photographique
15. Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice
16. Health-related quality of life and economic burden of prurigo nodularis
17. 27270 Prurigo nodularis and infectious disease hospitalizations: A national cross-sectional study
18. 27645 Health-related quality of life and economic burden of prurigo nodularis
19. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis
20. 26259 Prurigo nodularis associated pruritus is a systemic process affecting both nodular and interlesional skin
21. Clinical phenotyping of atopic dermatitis using combined itch and lesional severity
22. Emergency department use by patients with prurigo nodularis in the United States
23. A real-world study of the longitudinal course of itch severity and frequency in adults with atopic dermatitis
24. Reliability and Longitudinal Course of Itch/Scratch Severity in Adults With Atopic Dermatitis
25. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
26. Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic Dermatitis
27. A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice
28. Association of itch triggers with atopic dermatitis severity and course in adults
29. Association of atopic dermatitis severity with cognitive function in adults
30. Prevalence of prurigo nodularis in the United States
31. Measurement Properties of 4 Patient-Reported Outcome Measures to Assess Sleep Disturbance in Adults With Atopic Dermatitis
32. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis
33. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients
34. Cost-of-illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden-A population-based register-linkage study
35. A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom
36. Development of a Framework Based on Reflective MCDA to Support Patient–Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States
37. Relationship between symptoms and health-related quality of life benefits in patients with carcinoid syndrome: post-hoc analyses from TELESTAR
38. Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
39. Treatment patterns among patients with metastatic GEP-NET treated at a tertiary referral center.
40. Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
41. OP19 Unlocking The Potential Of Established Products: Need For Incentives
42. PP039 Health Utility Values In Renal Cell Carcinoma: A Systematic Review
43. Mitigating the Paucity-of-Data Problem for Target Population Sizing: Exploring a Model-Based Approach for Advanced Gastroenteropancreatic Neuroendocrine Tumours
44. Unlocking the potential of established products: toward new incentives rewarding innovation in Europe
45. Treatment Patterns and Economic Burden in Patients Treated for Acromegaly in the USA
46. AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
47. Infectious endocarditis caused by Helcococcus kunzii in a vascular patient: a case report and literature review
48. Association of progression-free survival with overall survival (OS) in patients (pts) with neuroendocrine tumor (NET) treated with somatostatin analogs.
49. Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
50. A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.